REGISTERED
on 21 Feb 2023
Last Applicant/ Owned by
554 W
113TH ST
NY
10025
Serial Number
97232923 filed on 21st Jan 2022
Registration Number
6985640 registered on 21st Feb 2023
Filing Basis
1. use application currently
Disclaimer
NO DATA
WAKEGENE
Antihypertensives; Dermatologicals; Animal feed additive for use as a nutritional supplement for medical purposes; Anti-diabetic pharmaceuticals; Dietary and nutritional supplements; Dietary food supplements; Dietary supplements; Dietetic foods and beverages adapted for medical use; Food for enteral feeding; Food supplements; Medical diagnostic reagents; Medicated shampoo; Multivitamin preparation Read More
Classification Information
Class [005]
Pharmaceutical Products
Antihypertensives; Dermatologicals; Animal feed additive for use as a nutritional supplement for medical purposes; Anti-diabetic pharmaceuticals; Dietary and nutritional supplements; Dietary food supplements; Dietary supplements; Dietetic foods and beverages adapted for medical use; Food for enteral feeding; Food supplements; Medical diagnostic reagents; Medicated shampoo; Multivitamin preparations; Nutraceuticals for use as a dietary supplement
First Use Date in General
29th Nov 2021
First Use Date in Commerce
29th Nov 2021
Specimens
Mark Details
Serial Number
No 97232923
Mark Type
No Service/Collective Mark
Attorney Docket Number
No US035573T
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 21st Feb 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 21st Feb 2023 | REGISTERED-PRINCIPAL REGISTER |
| 06th Dec 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 06th Dec 2022 | PUBLISHED FOR OPPOSITION |
| 16th Nov 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 31st Oct 2022 | ASSIGNED TO EXAMINER |
| 31st Oct 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 31st Oct 2022 | EXAMINER'S AMENDMENT ENTERED |
| 31st Oct 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 31st Oct 2022 | EXAMINERS AMENDMENT E-MAILED |